The Juvenile Diabetes Research Foundation (JDRF) announced that researchers at the Wilmer Eye Institute of Johns Hopkins…
Research
FDA Grants Diamyd Medical´s Diamyd Orphan Drug Designation
Diamyd Medical announced the Food and Drug Administration (FDA) granted its type 1 diabetes drug candidate Diamyd® Orpha…
JDRF, Pfizer, Hadassah Medical and the Hebrew University to Collaborate On Diabetes
The Juvenile Diabetes Research Foundation (JDRF) said that it will begin a diabetes research collaboration with Pfizer, …
Amylin and Takeda Advance Development of New Obesity Treatment
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study r…
Study Shows Vinegar Reduces Blood Glucose Levels
A new study shows vinegar reduces post-meal hyperglycemia in type 1 diabetics. While previous studies have shown that v…
Mechanism Leading to Diabetic Blindness Identified
Diabetic retinopathy is a common side effect of diabetes and the leading cause of blindness in young adults in the Unite…
Swedish Company, Diamyd Medical AB, Plans to Have Diabetes Vaccine by 2011
Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoim…
Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes R…
FDA Clears Clibra’s Insulin Patch
Calibra Medical Inc., formerly known as Seattle Medical Technologies Inc., announced today that the U.S. Food and Drug A…
JDRF Announces Diabetes Research Program with Johnson & Johnson
The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson…
